| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | serine-type peptidase activity | 1.19e-05 | 207 | 103 | 8 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 1.42e-05 | 212 | 103 | 8 | GO:0017171 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 7.88e-05 | 3 | 103 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity, type I | 2.61e-04 | 5 | 103 | 2 | GO:0005025 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 4.57e-04 | 190 | 103 | 6 | GO:0004252 | |
| GeneOntologyMolecularFunction | BMP receptor activity | 7.23e-04 | 8 | 103 | 2 | GO:0098821 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis of virus by host cell | 2.57e-05 | 12 | 103 | 3 | GO:0019065 | |
| GeneOntologyBiologicalProcess | endocytosis involved in viral entry into host cell | 4.23e-05 | 14 | 103 | 3 | GO:0075509 | |
| Domain | InsP3_rcpt-bd | 8.83e-05 | 3 | 102 | 2 | IPR000493 | |
| Domain | Latrophilin | 8.83e-05 | 3 | 102 | 2 | PF02354 | |
| Domain | GPCR_2_latrophilin_rcpt_C | 8.83e-05 | 3 | 102 | 2 | IPR003334 | |
| Domain | ARM-type_fold | 1.00e-04 | 339 | 102 | 9 | IPR016024 | |
| Domain | TRYPSIN_HIS | 2.52e-04 | 103 | 102 | 5 | IPR018114 | |
| Domain | TRYPSIN_SER | 2.88e-04 | 106 | 102 | 5 | PS00135 | |
| Domain | GPCR_2_latrophilin | 2.92e-04 | 5 | 102 | 2 | IPR003924 | |
| Domain | Lectin_gal-bd_dom | 2.92e-04 | 5 | 102 | 2 | IPR000922 | |
| Domain | Gal_Lectin | 2.92e-04 | 5 | 102 | 2 | PF02140 | |
| Domain | SUEL_LECTIN | 2.92e-04 | 5 | 102 | 2 | PS50228 | |
| Domain | TRYPSIN_HIS | 3.01e-04 | 107 | 102 | 5 | PS00134 | |
| Domain | Peptidase_S1A | 3.87e-04 | 113 | 102 | 5 | IPR001314 | |
| Domain | TRYPSIN_DOM | 4.20e-04 | 115 | 102 | 5 | PS50240 | |
| Domain | RIH_assoc | 4.37e-04 | 6 | 102 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 4.37e-04 | 6 | 102 | 2 | IPR013662 | |
| Domain | RIH_dom | 4.37e-04 | 6 | 102 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 4.37e-04 | 6 | 102 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 4.37e-04 | 6 | 102 | 2 | IPR015925 | |
| Domain | - | 4.37e-04 | 6 | 102 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 4.37e-04 | 6 | 102 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 4.37e-04 | 6 | 102 | 2 | PF08709 | |
| Domain | Tryp_SPc | 4.55e-04 | 117 | 102 | 5 | SM00020 | |
| Domain | Trypsin | 5.30e-04 | 121 | 102 | 5 | PF00089 | |
| Domain | Trypsin_dom | 5.30e-04 | 121 | 102 | 5 | IPR001254 | |
| Domain | Peptidase_S1_PA | 5.71e-04 | 123 | 102 | 5 | IPR009003 | |
| Domain | GS | 6.09e-04 | 7 | 102 | 2 | SM00467 | |
| Domain | GS_dom | 6.09e-04 | 7 | 102 | 2 | IPR003605 | |
| Domain | GS | 6.09e-04 | 7 | 102 | 2 | PS51256 | |
| Domain | TGF_beta_GS | 6.09e-04 | 7 | 102 | 2 | PF08515 | |
| Domain | GPS | 8.37e-04 | 34 | 102 | 3 | SM00303 | |
| Domain | GPS | 9.12e-04 | 35 | 102 | 3 | PF01825 | |
| Domain | GPS | 9.91e-04 | 36 | 102 | 3 | PS50221 | |
| Domain | GPS | 1.07e-03 | 37 | 102 | 3 | IPR000203 | |
| Domain | MIR | 1.29e-03 | 10 | 102 | 2 | PS50919 | |
| Domain | MIR | 1.29e-03 | 10 | 102 | 2 | PF02815 | |
| Domain | MIR | 1.29e-03 | 10 | 102 | 2 | SM00472 | |
| Domain | Activin_recp | 1.29e-03 | 10 | 102 | 2 | IPR000472 | |
| Domain | MIR_motif | 1.29e-03 | 10 | 102 | 2 | IPR016093 | |
| Domain | Activin_recp | 1.29e-03 | 10 | 102 | 2 | PF01064 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 1.35e-03 | 40 | 102 | 3 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 1.35e-03 | 40 | 102 | 3 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 1.35e-03 | 40 | 102 | 3 | PS50227 | |
| Domain | TRYPSIN_SER | 1.50e-03 | 90 | 102 | 4 | IPR033116 | |
| Domain | GAIN_dom_N | 1.57e-03 | 11 | 102 | 2 | IPR032471 | |
| Domain | GAIN | 1.57e-03 | 11 | 102 | 2 | PF16489 | |
| Domain | F-box-like | 1.78e-03 | 44 | 102 | 3 | PF12937 | |
| Domain | TGFB_receptor | 1.88e-03 | 12 | 102 | 2 | IPR000333 | |
| Domain | OLF | 2.22e-03 | 13 | 102 | 2 | PS51132 | |
| Domain | Olfac-like_dom | 2.22e-03 | 13 | 102 | 2 | IPR003112 | |
| Domain | OLF | 2.22e-03 | 13 | 102 | 2 | SM00284 | |
| Domain | OLF | 2.22e-03 | 13 | 102 | 2 | PF02191 | |
| Domain | CUB | 2.43e-03 | 49 | 102 | 3 | PF00431 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 2.57e-03 | 50 | 102 | 3 | PS00650 | |
| Domain | 7tm_2 | 2.57e-03 | 50 | 102 | 3 | PF00002 | |
| Domain | CUB | 2.57e-03 | 50 | 102 | 3 | SM00042 | |
| Domain | - | 2.88e-03 | 52 | 102 | 3 | 2.60.120.290 | |
| Domain | CUB | 3.04e-03 | 53 | 102 | 3 | PS01180 | |
| Domain | Ion_trans_dom | 3.53e-03 | 114 | 102 | 4 | IPR005821 | |
| Domain | Ion_trans | 3.53e-03 | 114 | 102 | 4 | PF00520 | |
| Domain | ARM-like | 3.65e-03 | 270 | 102 | 6 | IPR011989 | |
| Domain | CUB_dom | 3.74e-03 | 57 | 102 | 3 | IPR000859 | |
| Domain | PP2C | 3.81e-03 | 17 | 102 | 2 | IPR015655 | |
| Domain | GPCR_2_secretin-like | 4.32e-03 | 60 | 102 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 4.32e-03 | 60 | 102 | 3 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 4.52e-03 | 61 | 102 | 3 | PS50261 | |
| Domain | PP2C | 4.75e-03 | 19 | 102 | 2 | PF00481 | |
| Domain | PP2Cc | 5.26e-03 | 20 | 102 | 2 | SM00332 | |
| Domain | PPM-type_phosphatase_dom | 5.26e-03 | 20 | 102 | 2 | IPR001932 | |
| Domain | - | 5.26e-03 | 20 | 102 | 2 | 3.60.40.10 | |
| Domain | PPM_2 | 5.26e-03 | 20 | 102 | 2 | PS51746 | |
| Pubmed | Mutational analysis of the ligand binding site of the inositol 1,4,5-trisphosphate receptor. | 8.86e-06 | 2 | 104 | 2 | 8663526 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 15102710 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 15890645 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 28386233 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 9730621 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 10850425 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 28357470 | ||
| Pubmed | Inactivity of recombinant ELA2B provides a new example of evolutionary elastase silencing in humans. | 8.86e-06 | 2 | 104 | 2 | 16327289 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 15322331 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 1374893 | ||
| Pubmed | Latrophilin GPCRs direct synapse specificity by coincident binding of FLRTs and teneurins. | 8.86e-06 | 2 | 104 | 2 | 30792275 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 33183761 | ||
| Pubmed | BMPR1A and BMPR1B Missense Mutations Cause Primary Ovarian Insufficiency. | 8.86e-06 | 2 | 104 | 2 | 31769494 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 3646943 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 32764110 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 20673479 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 20813840 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 7559486 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 33646123 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 20843799 | ||
| Pubmed | Distinct roles of inositol 1,4,5-trisphosphate receptor types 1 and 3 in Ca2+ signaling. | 8.86e-06 | 2 | 104 | 2 | 14707143 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 10874040 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 10994649 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 9808793 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 26708753 | ||
| Pubmed | Role of type I receptors for anti-Müllerian hormone in the SMAT-1 Sertoli cell line. | 2.65e-05 | 3 | 104 | 2 | 15897891 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 20395455 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 24914938 | ||
| Pubmed | Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation. | 2.65e-05 | 3 | 104 | 2 | 22957045 | |
| Pubmed | The multiple actions of black widow spider toxins and their selective use in neurosecretion studies. | 2.65e-05 | 3 | 104 | 2 | 15066411 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 22992961 | ||
| Pubmed | Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans. | 2.65e-05 | 3 | 104 | 2 | 26584636 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 17437169 | ||
| Pubmed | Age-Associated Increase in BMP Signaling Inhibits Hippocampal Neurogenesis. | 2.65e-05 | 3 | 104 | 2 | 25538007 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 30167850 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 24048844 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 15673568 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 18194433 | ||
| Pubmed | Expression of bone morphogenetic protein receptors in the developing mouse metanephros. | 2.65e-05 | 3 | 104 | 2 | 11701996 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 18547250 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 36350267 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 12032348 | ||
| Pubmed | IP3 receptors regulate vascular smooth muscle contractility and hypertension. | 2.65e-05 | 3 | 104 | 2 | 27777977 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 11413485 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 31098411 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 26009177 | ||
| Pubmed | Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line. | 2.65e-05 | 3 | 104 | 2 | 17581770 | |
| Pubmed | Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction. | 2.65e-05 | 3 | 104 | 2 | 18241669 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 16432712 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 8707881 | ||
| Pubmed | Receptor-activated single channels in intact human platelets. | 2.65e-05 | 3 | 104 | 2 | 1693919 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 19068129 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 23955339 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 31979185 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 11714695 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 23831617 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 35339191 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 2.65e-05 | 3 | 104 | 2 | 24904548 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 12421829 | ||
| Pubmed | The type I BMP receptor ACVR1/ALK2 is required for chondrogenesis during development. | 2.65e-05 | 3 | 104 | 2 | 25413979 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 17327232 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 20363875 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 19726563 | ||
| Pubmed | Primary structure of human pancreatic elastase 2 determined by sequence analysis of the cloned mRNA. | 2.65e-05 | 3 | 104 | 2 | 3427074 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 16014380 | ||
| Pubmed | BMP signaling specifies the development of a large and fast CNS synapse. | 2.65e-05 | 3 | 104 | 2 | 23708139 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 7750489 | ||
| Pubmed | BMPR1a and BMPR1b signaling exert opposing effects on gliosis after spinal cord injury. | 2.65e-05 | 3 | 104 | 2 | 20130193 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 17890015 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 18250332 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. | 2.65e-05 | 3 | 104 | 2 | 23983250 | |
| Pubmed | Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes. | 2.65e-05 | 3 | 104 | 2 | 9858485 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 21040849 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 20427533 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 32620897 | ||
| Pubmed | Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours. | 2.65e-05 | 3 | 104 | 2 | 8605097 | |
| Pubmed | alpha-Latrotoxin and its receptors: neurexins and CIRL/latrophilins. | 2.65e-05 | 3 | 104 | 2 | 11520923 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 25549087 | ||
| Pubmed | Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation. | 2.65e-05 | 3 | 104 | 2 | 8592941 | |
| Pubmed | HSD17B7 NAA60 ICE2 INTS1 MFSD4A IL23A SLC22A12 GLMP LRRC25 XKR5 PLXNA2 SEZ6L | 3.95e-05 | 985 | 104 | 12 | 12975309 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 25215520 | ||
| Pubmed | Bone morphogenetic protein 4 (BMP4) signaling in retinoblastoma cells. | 5.29e-05 | 4 | 104 | 2 | 21152263 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 22293501 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 10712517 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptor interacts with the SNARE domain of syntaxin 1B. | 5.29e-05 | 4 | 104 | 2 | 21424589 | |
| Pubmed | Bone morphogenetic proteins, eye patterning, and retinocollicular map formation in the mouse. | 5.29e-05 | 4 | 104 | 2 | 18614674 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 32202499 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 22971142 | ||
| Pubmed | BRAM1, a BMP receptor-associated molecule involved in BMP signalling. | 5.29e-05 | 4 | 104 | 2 | 9663660 | |
| Pubmed | Nitric oxide-mediated regulation of β-amyloid clearance via alterations of MMP-9/TIMP-1. | 5.29e-05 | 4 | 104 | 2 | 23016931 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 11401330 | ||
| Pubmed | HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression. | 5.29e-05 | 4 | 104 | 2 | 24904118 | |
| Pubmed | LTP of inhibition at PV interneuron output synapses requires developmental BMP signaling. | 5.29e-05 | 4 | 104 | 2 | 32572071 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 28615414 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 17913790 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 10828023 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 23884412 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 26147384 | ||
| Pubmed | Regulation of InsP3 receptor activity by neuronal Ca2+-binding proteins. | 5.29e-05 | 4 | 104 | 2 | 14685260 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 11282024 | ||
| Cytoband | 3q13.33 | 4.39e-05 | 30 | 104 | 3 | 3q13.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q33 | 2.72e-04 | 55 | 104 | 3 | chr13q33 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 4.55e-05 | 3 | 71 | 2 | 297 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily L | 9.08e-05 | 4 | 71 | 2 | 918 | |
| GeneFamily | Type 1 receptor serine/threonine kinases | 3.15e-04 | 7 | 71 | 2 | 345 | |
| GeneFamily | Cyclins|F-boxes other | 4.79e-04 | 39 | 71 | 3 | 560 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 8.87e-04 | 394 | 71 | 7 | 471 | |
| Coexpression | GSE6259_CD4_TCELL_VS_CD8_TCELL_DN | 6.82e-07 | 184 | 103 | 8 | M6739 | |
| Coexpression | GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN | 1.45e-05 | 200 | 103 | 7 | M5801 | |
| ToppCell | LPS_only-Hematopoietic_Mast-Mast_cells-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-06 | 150 | 103 | 6 | ccb782fbcb3122266354a112a9a850506664f44d | |
| ToppCell | LPS_only-Hematopoietic_Mast-Mast_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-06 | 150 | 103 | 6 | 7290e9a812b1b2f919e67ccde0acf52687ab138f | |
| ToppCell | LPS_only-Hematopoietic_Mast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-06 | 150 | 103 | 6 | 2c5078a1f769ba8153dee756b53d28eb7b434a96 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Mast-Mast_cells-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-06 | 151 | 103 | 6 | b85a763459a0f019d1f9975d09b9f2247d62c9d3 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-06 | 171 | 103 | 6 | 1eebd7138c3b20ddc1104f21615f9df0e776bbe6 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-06 | 184 | 103 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-06 | 184 | 103 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-06 | 184 | 103 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 15-Distal-Immune-Hematopoietic,_T_Cells|Distal / Age, Tissue, Lineage and Cell class | 4.58e-06 | 185 | 103 | 6 | 481e3d3b63f2e5b4783088523c3cf70a461aed27 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-ILC3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.72e-06 | 186 | 103 | 6 | ac1d2a94674bd15885e70502abad3a2ff3c21d73 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILC3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.87e-06 | 187 | 103 | 6 | a037631a01d2cce088e6522dceeb1eee806522a1 | |
| ToppCell | 18-Airway-Immune-Immune|Airway / Age, Tissue, Lineage and Cell class | 5.33e-06 | 190 | 103 | 6 | 09e6bbe4f1be48153dc6cd647a57a0b531b8bf99 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.83e-06 | 193 | 103 | 6 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.83e-06 | 193 | 103 | 6 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.01e-06 | 194 | 103 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-SELL+_CD8_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.75e-06 | 198 | 103 | 6 | 0dac00a64fe08ec6669af3ddd4b82413b673233d | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.95e-06 | 199 | 103 | 6 | c9e1ac9f0fba23250a5df4052559d18d16df4521 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.15e-06 | 200 | 103 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.15e-06 | 200 | 103 | 6 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.15e-06 | 200 | 103 | 6 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.99e-05 | 142 | 103 | 5 | e160f35b3c18e77c4107fe96db5f56227c91785e | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast-Mast_cells-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-05 | 147 | 103 | 5 | 1ecd7c084e73eb6fae1ab1f9aae17115d3d62cbd | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast-Mast_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.51e-05 | 149 | 103 | 5 | 59aa1f2a5cbeba64c4529fb05f544db17fd8b188 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.51e-05 | 149 | 103 | 5 | 1527cdd98a2734cbf8ce4c6170557280b71c55cb | |
| ToppCell | Dividing_Macrophages-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 2.76e-05 | 152 | 103 | 5 | e39cfc346b35235546b303e7d73e4d9d7120a5fb | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-05 | 154 | 103 | 5 | d2aa24c593a1c0c6f186b74a18438b64b4e59701 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-05 | 155 | 103 | 5 | c58a5fb8d853f12204e961d633e83452eb12a659 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-05 | 155 | 103 | 5 | 9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.53e-05 | 160 | 103 | 5 | 8aaf6ac4f33ea291387fdbf9ff1a91d559391774 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-05 | 160 | 103 | 5 | 9e238e7cb31070a5b9da73b4bfddde54b969b0fd | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-05 | 160 | 103 | 5 | 3a5a7984d9ffcb0fbada02b95ffd7aca091acf30 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-05 | 160 | 103 | 5 | 32a105b99fc565c944672f518d6947dcf9ea8832 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-05 | 161 | 103 | 5 | 16f77e7a5444d2f2b210362816cd7a07b9b42af6 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-05 | 161 | 103 | 5 | f5821f551cf5c64c9f75cdb723492c87aac1ece0 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-05 | 161 | 103 | 5 | 58a32a1033f379579697bda1bbf047a088e4a34f | |
| ToppCell | 343B-Lymphocytic-ILC|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.21e-05 | 166 | 103 | 5 | a54377c703efff42d2cc1a8fdb610facc58053dd | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 169 | 103 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.71e-05 | 170 | 103 | 5 | a6fa0cab1fa829ec601fe48306b4c43c83425b04 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.71e-05 | 170 | 103 | 5 | b40255eee45eb18b5a297336d7f3845fd8f8aa3b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 170 | 103 | 5 | c4f00c1acde1d3b521101e469101d10fd257653e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 170 | 103 | 5 | d3c1edaf0190d8927578043c372dba7477e75e14 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 4.85e-05 | 171 | 103 | 5 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | facs-GAT-Fat-24m-Epithelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 173 | 103 | 5 | 815ba48a9222ea09ba8005e2d2f7c5addf118ad1 | |
| ToppCell | facs-GAT-Fat-24m-Epithelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 173 | 103 | 5 | 98e464d9e6d6b69421e9e4041b638b6825247f60 | |
| ToppCell | facs-GAT-Fat-24m-Epithelial-epithelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 173 | 103 | 5 | 3e6f0a08eddfd61871f7a85acccf6d539af6ebda | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 174 | 103 | 5 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.56e-05 | 176 | 103 | 5 | dbc4f64cd39b229f2355ca1d0215cc7f6a767dce | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-NK_T_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.56e-05 | 176 | 103 | 5 | 1ea45cf7b7e12206c3eca1594173368643c50e59 | |
| ToppCell | Control-Lymphocytic_NKT-T_cells-T-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.86e-05 | 178 | 103 | 5 | 910f8bea19d335455aba24e6a07b4834b709db5d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.02e-05 | 179 | 103 | 5 | 716856b2c7c660bf5ce00e63efeda6ed121f2baa | |
| ToppCell | Control-Lymphocytic_NKT-T_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.02e-05 | 179 | 103 | 5 | d892d9496f1c33e23312092591eb2e968e736f7d | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR-_ILC3|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.18e-05 | 180 | 103 | 5 | 3f0a692ad2823951e0ec23d0452f436c5f5c09c0 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 6.34e-05 | 181 | 103 | 5 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-SELL+_CD4_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.51e-05 | 182 | 103 | 5 | 7dd435e456da1470d19d3db307ae4909c25d2f0d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.51e-05 | 182 | 103 | 5 | 09d0793245d3d77ab5fc384c0b62637f736da50b | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 6.68e-05 | 183 | 103 | 5 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR-_ILC3|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.68e-05 | 183 | 103 | 5 | 2c0b1265af2bca2c378ff7104bce337c98053b5e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.68e-05 | 183 | 103 | 5 | c7fedb5b0c1f17b3391ce1c4a6bfca7615c359c5 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.68e-05 | 183 | 103 | 5 | d4a558bc0b8e11be195a7da1468ab38eb477117d | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-T_&_ILC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.86e-05 | 184 | 103 | 5 | 51ae0963b4fb034c3f605ee4e5da513cba7aca35 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-SELL+_CD8_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.86e-05 | 184 | 103 | 5 | c80acd6a81a3633d72813a77223879d0be254f93 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.22e-05 | 186 | 103 | 5 | 428b4cbee3d3ab666cab2fc2d9c815318359e458 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.40e-05 | 187 | 103 | 5 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.40e-05 | 187 | 103 | 5 | 42b20d7f0a4f9195b3d71dc0e089b5e0914ebcbb | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.59e-05 | 188 | 103 | 5 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.59e-05 | 188 | 103 | 5 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | droplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.59e-05 | 188 | 103 | 5 | 0ec2a1b0505501ba18f10a5fce68c306a6292419 | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.78e-05 | 189 | 103 | 5 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 7.98e-05 | 190 | 103 | 5 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.38e-05 | 192 | 103 | 5 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | ASK428-Immune-T_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.38e-05 | 192 | 103 | 5 | 121cb8c61002f20e1d287b8a7e67a30bb163e74a | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.38e-05 | 192 | 103 | 5 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.38e-05 | 192 | 103 | 5 | 445985fe1bcd33e4f0a1704b27988fbfc9334538 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR-_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.59e-05 | 193 | 103 | 5 | d8e6a7f1da4506acaa06380b4aec3fe299ec8b7e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.59e-05 | 193 | 103 | 5 | 7deb439943d35a4e825674b2b7dcddb45d366ad1 | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.59e-05 | 193 | 103 | 5 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.59e-05 | 193 | 103 | 5 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.59e-05 | 193 | 103 | 5 | afdf92ecace145407d57192dde5d0dac0bc37ee9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.59e-05 | 193 | 103 | 5 | bbe642f8b66ba9d028709deaf847f2f7e73be04f | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.80e-05 | 194 | 103 | 5 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.80e-05 | 194 | 103 | 5 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.80e-05 | 194 | 103 | 5 | c49f3341a19128855f084bcf18ef3da4bab79099 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.80e-05 | 194 | 103 | 5 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.80e-05 | 194 | 103 | 5 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.80e-05 | 194 | 103 | 5 | da88e8c11e55df296d2533f1d1575779cdf3edd7 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.80e-05 | 194 | 103 | 5 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.80e-05 | 194 | 103 | 5 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.01e-05 | 195 | 103 | 5 | 441345d33f839a9e9222e790752b5603ff572bf2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.01e-05 | 195 | 103 | 5 | 2d485373bfd9bb4bb9236bf0b31d03e132c8018f | |
| ToppCell | 15-Airway-Immune-Hematopoietic,_T_Cells|Airway / Age, Tissue, Lineage and Cell class | 9.01e-05 | 195 | 103 | 5 | ec392fc8bd2c0f1e3a79f2e401608fd6ba8d339c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.23e-05 | 196 | 103 | 5 | ab6022041c33617bca3ed0c62f19673cd2750da9 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.23e-05 | 196 | 103 | 5 | 008e7593ab26988b957673f863bdd017516281ae | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.23e-05 | 196 | 103 | 5 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.46e-05 | 197 | 103 | 5 | d0962c94f4b07759b0c9dade75c39fd2deec2f21 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 9.46e-05 | 197 | 103 | 5 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | BAL-Control-cDC_5|Control / Compartment, Disease Groups and Clusters | 9.46e-05 | 197 | 103 | 5 | 8a3fe59be3ed1f0254cc8c60b99c840193370efb | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD8-gdT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 198 | 103 | 5 | 9dc91a1101eef649a301f0147ecd5c028a9c2b12 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD4|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 198 | 103 | 5 | 8d86b5c875d4663ea4d61f50a4eaff1883d97641 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.92e-05 | 199 | 103 | 5 | 017d67582f80d90f20b3d02044fa2e32f3dff289 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-CD4_T|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.92e-05 | 199 | 103 | 5 | 992bc4f0dc4189f18773c55976eb124c3827e08b | |
| Disease | carotid plaque build | 1.80e-04 | 84 | 98 | 4 | EFO_0006501 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 7.05e-04 | 12 | 98 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 8.32e-04 | 13 | 98 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | cystic fibrosis (is_marker_for) | 1.17e-03 | 62 | 98 | 3 | DOID:1485 (is_marker_for) | |
| Disease | Cannabis use | 1.27e-03 | 16 | 98 | 2 | EFO_0007585 | |
| Disease | pulmonary hypertension (is_marker_for) | 1.28e-03 | 64 | 98 | 3 | DOID:6432 (is_marker_for) | |
| Disease | Eye Abnormalities | 1.44e-03 | 17 | 98 | 2 | C0015393 | |
| Disease | Female Urogenital Diseases | 1.61e-03 | 18 | 98 | 2 | C1720887 | |
| Disease | mucocutaneous lymph node syndrome | 2.10e-03 | 76 | 98 | 3 | EFO_0004246 | |
| Disease | Down syndrome (is_marker_for) | 2.42e-03 | 22 | 98 | 2 | DOID:14250 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSQIAPLCWEQRNHS | 206 | P60509 | |
| WTQAKLESHSTPCSL | 1466 | Q9HCE0 | |
| SLLAASNPSLVNNCW | 51 | Q9N2K0 | |
| WLHSCDTNITTPKLE | 601 | Q86UK0 | |
| INAICSQWLPISHAV | 341 | Q7Z2Z2 | |
| DLSNCSSPWVNHITQ | 546 | Q9HAR2 | |
| PQTSLCLLWNQAAAS | 5851 | Q8WXG9 | |
| HNTSLDQPCVKRWSA | 166 | Q8WXK1 | |
| PDLSNCTSHWVNQLA | 516 | O95490 | |
| SLIANSWVLTAAHCI | 61 | P08217 | |
| TECWAHNPASRLTAL | 471 | O00238 | |
| CLWDTLVAPANSLVH | 2866 | Q9Y485 | |
| LTDPEQRCLHWSLLS | 291 | Q6P387 | |
| LSWIHPESQATITRC | 291 | Q13613 | |
| LPCVWNVQLSDHTLA | 311 | Q8N3Y3 | |
| HLCTNTWIQSTNVPI | 391 | Q14573 | |
| SENARLALCEHPQWT | 611 | Q92621 | |
| SISIPLNSWSACHRD | 261 | Q8N7Z5 | |
| HGVCSTWLNSLKPQD | 941 | P35228 | |
| FLSPEQHACSWQLLL | 51 | Q8TAT2 | |
| LTRHCQLLETPESWA | 1586 | P52948 | |
| NCWSEAAPLLVHVSS | 446 | Q8WZ60 | |
| HNTKTTSWLDPRCLN | 321 | Q96QZ7 | |
| CHLQQVTDLPWTSVS | 236 | O95944 | |
| LTSLTSDDNLWACLH | 241 | Q8NFG4 | |
| LTGDCQKNIHLWTPT | 231 | Q9BQ67 | |
| HQSSWPTLHQCIRVL | 1666 | Q8N201 | |
| DLRCQTHSSLPQISW | 41 | Q8N468 | |
| TLCRNSVLWPHSHNQ | 181 | Q9NYK6 | |
| RHLCTNTWVHSTNIP | 391 | Q14643 | |
| TCTRSSQPWQAALLA | 46 | Q9P0G3 | |
| QAHSLLCSFLPWSGI | 216 | Q9H7X0 | |
| NHLWLLEGTPSLQSC | 71 | Q8IZA0 | |
| PLLCWDTTSSQHNLS | 136 | Q8N386 | |
| TEAHLLPLWLSTTNQ | 491 | Q9BZQ6 | |
| LDWSSHNVKCSNPQI | 846 | O75051 | |
| NCITSLQLHPKGWAT | 411 | Q5QP82 | |
| NDTIRNSDSLWKPHC | 66 | Q5FWF7 | |
| QHCVWSSSLQQCLSP | 2081 | Q7Z7M0 | |
| WLTGALHLCSPLTSQ | 256 | P42785 | |
| SHQCSLDWLLLGPAA | 96 | O75074 | |
| WPRLQHLNLSSCSQL | 151 | Q8WV35 | |
| SLSQEHVESLCWLLS | 1226 | Q86WI3 | |
| CQLSQPEVAAHTWLL | 4361 | Q5VST9 | |
| ALCSNPIGQLHKTWA | 321 | Q8IZJ4 | |
| LAQVWAQQIHSPLTC | 191 | A6NGY1 | |
| QSQLANLTVCHPAWS | 166 | O43603 | |
| LCRLWTESLLHSNSS | 791 | Q659A1 | |
| SLIANSWVLTAAHCI | 61 | P08218 | |
| HSSQWKDPALSQLIC | 131 | P24522 | |
| VQWNPCALLHSSTCS | 896 | O75417 | |
| LSQKLCTLAWSAHPL | 36 | Q9NPF7 | |
| CSGQHWSITNVLRSL | 591 | Q6P9A2 | |
| SECWAHNPASRLTAL | 501 | P36894 | |
| LLCHSDNPSQLIWTS | 156 | P56937 | |
| TLWCGLNHSLVLSQS | 411 | O75426 | |
| HCPNILTDRSLWLAS | 666 | Q8TF61 | |
| NTPHSTLSVNWSLLL | 86 | Q8WWB7 | |
| WRSSENHPNLTCTAS | 416 | Q9HBG7 | |
| WALLLTICPSTQISH | 306 | Q12894 | |
| HPTTALCNIWDNTLL | 246 | Q8NHY5 | |
| GWTTISQLTQILSHC | 76 | Q15051 | |
| EASLSTAPSCHQQTW | 561 | Q8NFN8 | |
| VELCSSDSLQWLPCH | 881 | Q86VF2 | |
| DLENHNSQLNWCSSP | 501 | P42566 | |
| NSQLNWCSSPHSILV | 506 | P42566 | |
| PDWLCHSSSNTAEIQ | 6876 | Q8NDH2 | |
| PIHISWLSLSRVNCS | 26 | Q16667 | |
| LLWQTSHSCLVFQPV | 216 | Q86SQ9 | |
| SHRCWAPLLDNSTAQ | 46 | Q96S37 | |
| NLLWLALACSPVHTT | 6 | Q9BWS9 | |
| SLTCHSISPQMWQLL | 661 | O15397 | |
| ACWSPHTLLQSLDQL | 236 | Q9UJJ7 | |
| LGWDSVQLSACHLLT | 21 | Q5VWG9 | |
| SLLNLSIWHPNQSTT | 156 | A5PLK6 | |
| QWAIHPTFNLKSLSC | 256 | Q8IUD6 | |
| SLLSPQWVLTAAHCF | 66 | Q9NRR2 | |
| LTCINASKPHWSSQE | 431 | Q9BYH1 | |
| SQVNSLPAEWCEALH | 656 | Q5HYK7 | |
| SEQQPSWTDDLPLCH | 11 | Q15750 | |
| SHRCWVPLLDNDTVS | 46 | Q8N4F4 | |
| SHLLGPQSCWSSQKE | 211 | Q5JR12 | |
| RPTAEICLSHSWLQQ | 281 | O94768 | |
| RATLIISPSSICHQW | 716 | Q149N8 | |
| ISPSSICHQWVDEIN | 721 | Q149N8 | |
| QSSCHVLWAPADINL | 861 | Q14191 | |
| NISSGHCILTWSISP | 156 | Q01113 | |
| SDTQASITLNLPNCW | 311 | Q495N2 | |
| LPTSHLDLACSLLWN | 616 | P36956 | |
| LLHITTCSFVAPWNS | 116 | P01033 | |
| LDWLCHLLTSDASSP | 641 | Q63HN8 | |
| LTNHLSIWFATCLSI | 91 | Q9NYW3 | |
| DIQPWLHSGSNSLLS | 381 | Q9H900 | |
| HQCGASLISNTWLLT | 231 | Q6ZWK6 | |
| HSNKPAQSDNLTIWC | 341 | P40200 | |
| LPHSSILRTWLSKCQ | 236 | Q9H5L6 | |
| LALTSNSSWVQCPSH | 571 | P29144 | |
| LWLLNNLTANSPSFC | 361 | Q96DC7 | |
| SLLTANEHWTPCILN | 226 | Q709C8 | |
| QLVNLTCLVWTTHPA | 1101 | Q9BZZ2 | |
| LCTSLPVWLENHTAL | 321 | P22102 | |
| LSPETKHCILSWLGN | 391 | Q14139 | |
| SLLHPKSTDIWQGCL | 316 | Q6UX68 | |
| QDLHATIQNWPSSSC | 646 | Q6WRX3 | |
| SLFPHANEWLKNCTT | 201 | Q8NA31 | |
| SWLLLGSLTHNAVCP | 2416 | Q9P2D8 | |
| SLQTRTSWSAHQPCL | 921 | Q96L42 | |
| NVTWNSLAIPDTHCS | 216 | Q8IZF0 | |
| LLRAHCQTSGWSLTE | 346 | P22033 |